APOLLOHOSP — Apollo Hospitals Enterprise Income Statement
0.000.00%
- IN₹1.03tn
- IN₹1.09tn
- IN₹217.94bn
Annual income statement for Apollo Hospitals Enterprise, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 105,600 | 146,626 | 166,125 | 190,592 | 217,940 |
| Cost of Revenue | |||||
| Gross Profit | 48,758 | 70,891 | 80,382 | 92,537 | 104,840 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 99,206 | 127,783 | 151,602 | 173,480 | 195,160 |
| Operating Profit | 6,394 | 18,843 | 14,523 | 17,112 | 22,780 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,207 | 15,781 | 11,437 | 13,625 | 20,061 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,360 | 11,011 | 8,875 | 9,170 | 14,721 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,504 | 10,556 | 8,191 | 8,986 | 14,459 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,504 | 10,556 | 8,191 | 8,986 | 14,459 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 8.2 | 59.3 | 57.8 | 62.6 | 101 |
| Dividends per Share |